Merck KGaA (MKGAF)
150.00
+0.79
(+0.53%)
USD |
OTCM |
May 22, 09:31
Merck EPS Diluted (Quarterly) : 1.773 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bayer AG | 0.8226 |
| Dermapharm Holding SE | 0.9822 |
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| AstraZeneca PLC | 0.9849 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 782.68M |
| Revenue (Quarterly) | 6.006B |
| Total Expenses (Quarterly) | 5.234B |
| Enterprise Value | 75.67B |
| Gross Profit Margin (Quarterly) | 59.70% |
| Profit Margin (Quarterly) | 13.03% |
| Earnings Yield | 4.50% |
| Operating Earnings Yield | 7.23% |
| Normalized Earnings Yield | 4.984 |